Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity

Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity

Objective This study aimed to evaluate the preference for antivascular endothelial growth factor (anti-VEGF) versus laser ablation therapy as primary and additional treatment in aggressive retinopathy of prematurity (ROP) and type 1 ROP.Methods This multicentre retrospective study was conducted at n...

Full description

Bibliographic Details
Main Authors: Sung Soo Kim, Sang Jun Park, Se Joon Woo, Jae Shin Song, Kiyoung Kim, Jae Yong Han, Ji Hye Jang, Yong Koo Kang, Han Sang Park, Hyun Wong Kim, Jong Wook Bang, Kwang Sic Joo, Woong-Sun Yoo, Inyoung Chung, Yong-Wun Cho, Jong Hyun Lee, Hun Jin Choi, Yoo-Ri Chung
Format: Article
Language:English
Published: BMJ Publishing Group 2023-06-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/8/1/e001166.full

Internet

https://bmjophth.bmj.com/content/8/1/e001166.full

Similar Items